GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » EV-to-FCF

Shanghai HeartCare Medical Technology (HKSE:06609) EV-to-FCF : -23.15 (As of Apr. 09, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai HeartCare Medical Technology's Enterprise Value is HK$329.5 Mil. Shanghai HeartCare Medical Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-14.2 Mil. Therefore, Shanghai HeartCare Medical Technology's EV-to-FCF for today is -23.15.

The historical rank and industry rank for Shanghai HeartCare Medical Technology's EV-to-FCF or its related term are showing as below:

HKSE:06609' s EV-to-FCF Range Over the Past 10 Years
Min: -44.83   Med: -0.28   Max: 1.8
Current: -26

During the past 6 years, the highest EV-to-FCF of Shanghai HeartCare Medical Technology was 1.80. The lowest was -44.83. And the median was -0.28.

HKSE:06609's EV-to-FCF is ranked worse than
100% of 389 companies
in the Medical Devices & Instruments industry
Industry Median: 24.92 vs HKSE:06609: -26.00

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-09), Shanghai HeartCare Medical Technology's stock price is HK$27.00. Shanghai HeartCare Medical Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.386. Therefore, Shanghai HeartCare Medical Technology's PE Ratio (TTM) for today is At Loss.


Shanghai HeartCare Medical Technology EV-to-FCF Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology EV-to-FCF Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial - -8.21 -1.51 -2.70 -

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1.51 - -2.70 - -

Competitive Comparison of Shanghai HeartCare Medical Technology's EV-to-FCF

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's EV-to-FCF falls into.


;
;

Shanghai HeartCare Medical Technology EV-to-FCF Calculation

Shanghai HeartCare Medical Technology's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=329.491/-14.234
=-23.15

Shanghai HeartCare Medical Technology's current Enterprise Value is HK$329.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai HeartCare Medical Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-14.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai HeartCare Medical Technology  (HKSE:06609) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shanghai HeartCare Medical Technology's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=27.00/-0.386
=At Loss

Shanghai HeartCare Medical Technology's share price for today is HK$27.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai HeartCare Medical Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.386.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shanghai HeartCare Medical Technology EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai HeartCare Medical Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.
Executives
Wang Guohui
Ding Kui 2201 Interest of corporation controlled by you
Wisary Limited 2101 Beneficial owner
Li Jun 2201 Interest of corporation controlled by you
Shanghai Yuxinan Enterprise Management Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology Headlines

No Headlines